Postibrutinib relapse outcomes for patients with marginal zone lymphoma.

ABSTRACT:

SUBMITTER: Epperla N 

PROVIDER: S-EPMC9827027 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature